Not yet recruiting
A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell Carcinoma
NCT07446335
- Conditions
- Advanced Esophageal Squamous Cell Carcinoma
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China